Cited by 2,641Clostridium difficile and Clostridium perfringens researchInfection Control in HealthcareAntimicrobial Resistance in Staphylococcus

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Burden of Clostridium difficile Infection in the United States

Open access

Lessa, Fernanda C., Mu, Yi, Bamberg, Wendy M., Beldavs, Zintars G., Dumyati, Ghinwa K., Dunn, John R., Farley, Monica M., Holzbauer, Stacy M., Meek, James I., Phipps, Erin C., Wilson, Lucy E., Winston, Lisa G., Cohen, Jessica A., Limbago, Brandi M., Fridkin, Scott K., Gerding, Dale N., McDonald, L. Clifford·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1408913PMC PMC10966662

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The magnitude and scope of Clostridium difficile infection in the United States continue to evolve. METHODS: In 2011, we performed active population- and laboratory-based surveillance across 10 geographic areas in the United States to identify cases of C. difficile infection (stool specimens positive for C. difficile on either toxin or molecular assay in residents ≥ 1 year of age). Cases were classified as community-associated or health care-associated. In a sample of cases of C. difficile infection, specimens were cultured and isolates underwent molecular typing. We used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection. RESULTS: A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were health care-associated, but only 24.2% had onset during hospitalization. After adjustment for predictors of disease incidence, the estimated number of incident C. difficile infections in the United States was 453,000 (95% confidence interval [CI], 397,100 to 508,500). The incidence was estimated to be higher among females (rate ratio, 1.26; 95% CI, 1.25 to 1.27), whites (rate ratio, 1.72; 95% CI, 1.56 to 2.0), and persons 65 years of age or older (rate ratio, 8.65; 95% CI, 8.16 to 9.31). The estimated number of first recurrences of C. difficile infection was 83,000 (95% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100). The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community-associated infections (30.7% vs. 18.8%, P<0.001). CONCLUSIONS: C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011. (Funded by the Centers for Disease Control and Prevention.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1408913

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Self-citation
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pépin, J., & Wilcox, M. H. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,931
Self-citation
Sampling: Design and Analysis
Ziegel, E. R., & Lohr, S. L. (2000) · Technometrics · doi:10.2307/1271491 · Cited by 2,452
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G., Thompson, A. D., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,020
Self-citation
A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M., Michaud, S., Bourgault, A., Nguyen, T., Frenette, C. H., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,962
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., BENTHEM, B. H. B. V., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,049
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, A., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 838
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R. P., Gerding, D. N., Nichol, G. M., Thomas, W. D., Leney, M. D., Sloan, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 743
Self-citation
Burden of Clostridium difficile on the Healthcare System
Dubberke, E. R., & Olsen, M. A. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis335 · Cited by 566
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
Planche, T., Davies, K., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O’Connor, L., Oakley, S. J., Pope, C. F., Wren, M. W. D., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70200-7 · Cited by 436

Flagged first, then by citations

Show all 44 references

Research works printed but not linked: 4

2005, MMWR Morb Mortal Wkly Rep, 54, 1201
Heitjan DF, 1991, J R Stat Soc Ser C Appl Stat, 40, 13
2014, Fed Regist, 79, 10524
2011, Fed Regist, 76, 51476

Sorted by citations

Items 801–900 of 1,002

Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant
Kamboj, M., Sheahan, A., Sun, J. Y., Taur, Y., Robilotti, E. V., Babady, E., Papanicolaou, G. A., Jakubowski, A. A., Pamer, E. G., & Sepkowitz, K. A. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.237 · Cited by 25
Faecal microbiota transplantation is promising but not a panacea
Sadowsky, M. J., & Khoruts, A. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.15 · Cited by 25
Using Spatial and Temporal Mapping to Identify Nosocomial Disease Transmission of Clostridium difficile
Murray, S. G., Yim, J. W. L., Croci, R., Rajkomar, A., Schmajuk, G., Khanna, R. R., & Cucina, R. J. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.5506 · Cited by 25
A qualitative, interprofessional analysis of barriers to and facilitators of implementation of the Department of Veterans Affairs' Clostridium difficile prevention bundle using a human factors engineering approach
Yanke, E. M., Moriarty, H., Carayon, P., & Safdar, N. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.08.027 · Cited by 25
The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation
Khoruts, A., Hoffmann, D. E., & Palumbo, F. B. (2019) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110519897726 · Cited by 26
The Impact of Clinical Decision Support Alerts onClostridioides difficileTesting: A Systematic Review
Dunn, A. N., Radakovich, N., Ancker, J. S., Donskey, C. J., & Deshpande, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa152 · Cited by 25
Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone
Kokai‐Kun, J. F., Le, C., Trout, K. W., Cope, J. L., Ajami, N. J., Degar, A. J., & Connelly, S. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s260258 · Cited by 25
Identification of the Clostridial cellulose synthase and characterization of the cognate glycosyl hydrolase, CcsZ
Scott, W., Lowrance, B., Anderson, A. C., & Weadge, J. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242686 · Cited by 25
Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis
Tariq, R., Laguio-Vila, M. R., Tahir, M. W., Orenstein, R., Pardi, D. S., & Khanna, S. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284821994046 · Cited by 25
Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile
Tixier, E. N., Verheyen, E., Luo, Y., Grinspan, L. T., Du, C., Ungaro, R. C., Walsh, S., & Grinspan, A. M. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06908-4 · Cited by 27
Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes
Lesniak, N. A., Schubert, A. M., Sinani, H., & Schloss, P. D. (2021) · mSphere · doi:10.1128/msphere.01238-20 · Cited by 26
Dietary fat promotes antibiotic-induced Clostridioides difficile mortality in mice
Hazleton, K. Z., Martin, C. G., Orlicky, D. J., Arnolds, K. L., Nusbacher, N. M., Moreno-Huizar, N., Armstrong, M., Reisdorph, N. A., & Lozupone, C. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00276-1 · Cited by 25
Structural basis for selective modification of Rho and Ras GTPases by Clostridioides difficile toxin B
Liu, Z., Zhang, S., Chen, P., Tian, S., Zeng, J., Perry, K., Dong, M., & Jin, R. (2021) · Science Advances · doi:10.1126/sciadv.abi4582 · Cited by 25
Leaky Gum: The Revisited Origin of Systemic Diseases
Park, D.-Y., Park, J. Y., Lee, D., Hwang, I., & Kim, H. (2022) · Cells · doi:10.3390/cells11071079 · Cited by 25
Chronic Inflammatory Diseases and Green Tea Polyphenols
Oz, H. S. (2017) · Nutrients · doi:10.3390/nu9060660 · Cited by 25
Clinical Outcomes of Treated and Untreated C. difficile PCR-Positive/Toxin-Negative Adult Hospitalized Patients: a Quasi-Experimental Noninferiority Study
Hogan, C. A., Hitchcock, M. M., Frost, S., Kapphahn, K., Holubar, M. K., Tompkins, L. S., & Banaei, N. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02187-21 · Cited by 25
Identification of bacteriophage genome sequences with representation learning
Bai, Z., Zhang, Y., Miyano, S., Yamaguchi, R., Fujimoto, K., Uematsu, S., & Imoto, S. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac509 · Cited by 27
Antibiotic prophylaxis for tube thoracostomy placement in trauma: a practice management guideline from the Eastern Association for the Surgery of Trauma
Freeman, J. J., Asfaw, S. H., Vatsaas, C., Yorkgitis, B. K., Haines, K., Burns, J. B., Kim, D. S., Loomis, E. A., Kerwin, A. J., McDonald, A. A., et al. (2022) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2022-000886 · Cited by 25
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial
Garey, K. W., Dubberke, E. R., Guo, A. X., Harvey, A., Yang, M., García-Horton, V., Fillbrunn, M. K., Wang, H., Tillotson, G., Bancke, L. L., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad383 · Cited by 25
The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series
Akamine, C. M., Ing, M. B., Jackson, C. S., & Loo, L. K. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1657-1 · Cited by 25
Identifying environmental reservoirs of Clostridium difficile with a scent detection dog: preliminary evaluation
Bryce, E., Zurberg, T., Zurberg, M., Shajari, S., & Roscoe, D. L. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.05.023 · Cited by 25
A 3D intestinal tissue model supports Clostridioides difficile germination, colonization, toxin production and epithelial damage
Shaban, L., Ying, C., Fasciano, A. C., Lin, Y., Kaplan, D. L., Kumamoto, C. A., & Mecsas, J. C. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.02.006 · Cited by 25
In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile
Mathur, T., Barman, T. K., Kumar, M., Singh, D., Kumar, R., Khera, M. K., Yamada, M., Inoue, S., Upadhyay, D. J., & Masuda, N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02157-17 · Cited by 25
Novel FR-900493 Analogues That Inhibit the Outgrowth of Clostridium difficile Spores
Mitachi, K., Yun, H. G., Kurosu, S. M., Eslamimehr, S., Lemieux, M. R., Klaić, L., Clemons, W., & Kurosu, M. (2018) · ACS Omega · doi:10.1021/acsomega.7b01740 · Cited by 25
Transcriptomic profiling of Clostridium difficile grown under microaerophillic conditions
Giordano, N., Hastie, J. L., & Carlson, P. E. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty010 · Cited by 25
Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting
Lam, S. W., Neuner, E. A., Fraser, T. G., Delgado, D., & Chalfin, D. B. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.139 · Cited by 25
Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings
Appaneal, H. J., Caffrey, A. R., Beganovic, M., Avramovic, S., & LaPlante, K. L. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz032 · Cited by 25
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection
Burdet, C., Sayah‐Jeanne, S., Nguyen, T. T., Hugon, P., Sablier-Gallis, F., Saint-Lu, N., Corbel, T., Ferreira, S., Pulse, M., Weiss, W., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-18 · Cited by 25
Different molecular characteristics and antimicrobial resistance profiles of Clostridium difficile in the Asia-Pacific region
Luo, Y., Cheong, E. Y. L., Bian, Q., Collins, D. A., Ye, J., Shin, J. H., Yam, W. C., Takata, T., Song, X., Wang, X., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1682472 · Cited by 26
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options
Mizusawa, M., Doron, S., & Gorbach, S. L. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0289-2 · Cited by 27
Fecal microbiota transplantation in recurrent Clostridium difficile infection: A retrospective single‐center chart review
Kim, P., Gadani, A., Abdul‐Baki, H., Mitre, R., & Mitre, M. (2019) · JGH Open · doi:10.1002/jgh3.12093 · Cited by 24
Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in Clostridioides difficile
Pensinger, D. A., Dobrila, H. A., Stevenson, D. M., Hryckowian, N. D., Amador‐Noguez, D., & Hryckowian, A. J. (2024) · mBio · doi:10.1128/mbio.02535-23 · Cited by 24
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details
Monday, L., Tillotson, G., & Chopra, T. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s419243 · Cited by 24
Therapies on the horizon forClostridium difficileinfections
McFarland, L. V. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1161025 · Cited by 26
The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study
Nanwa, N., Kwong, J. C., Krahn, M. D., Daneman, N., Lu, H., Austin, P. C., Govindarajan, A., Rosella, L. C., Cadarette, S. M., & Sander, B. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.122 · Cited by 24
Antimicrobial Stewardship in the Management of Sepsis
Pulia, M. S., Redwood, R., & Sharp, B. R. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.09.007 · Cited by 25
Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China
Li, C., Duan, J., Liu, S., Meng, X., Fu, C., Zeng, C., & Wu, A. (2017) · Infection · doi:10.1007/s15010-017-1024-1 · Cited by 24
Increasing rates of Clostridium difficile infection in Mexican hospitals
Paláu-Dávila, L., Garza‐González, E., Rodríguez‐Zulueta, P., Morfín‐Otero, R., Rodríguez-Noriega, E., Vilar‐Compte, D., Rodríguez‐Aldama, J. C., & Camacho-Ortíz, A. (2017) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2017.05.007 · Cited by 24
Management of Clostridioides difficile colitis: insights for the gastroenterologist
Saha, S., & Khanna, S. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819847651 · Cited by 25
Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia
Rashidi, A., & Weisdorf, D. J. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.011 · Cited by 24
The small acid-soluble proteins of Clostridioides difficile are important for UV resistance and serve as a check point for sporulation
Nerber, H. N., & Sorg, J. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009516 · Cited by 24
Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection
Wang, S., Zhu, D., & Sun, X. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00263-22 · Cited by 24
Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases
Mahmoudi, H., & Hossainpour, H. (2022) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_131_22 · Cited by 25
Spore-Forming Clostridium ( Clostridioides ) difficile in Wastewater Treatment Plants in Western Australia
Chisholm, J. M., Putsathit, P., Riley, T. V., & Lim, S. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03582-22 · Cited by 24
A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections
Malone, D. C., Armstrong, E. P., Gratie, D., Pham, S. V., & Amin, A. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.369 · Cited by 24
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota–Based Therapeutic
Berenson, C. S., Lashner, B. A., Korman, L. Y., Hohmann, E. L., Deshpande, A., Louie, T., Sims, M. D., Pardi, D. S., Kraft, C. S., Wang, E. E. L., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad448 · Cited by 24
Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice
Tariq, R., Weatherly, R. M., Kammer, P. P., Pardi, D. S., & Khanna, S. (2017) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2017.05.002 · Cited by 23
Penetrating the Bacterial Biofilm
Teirlinck, E., Samal, S. K., Coenye, T., & Braeckmans, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-41625-2.00003-x · Cited by 25
A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis
Kirkwood, K. A., Gulack, B. C., Iribarne, A., Bowdish, M. E., Greco, G., Mayer, M. L., O’Sullivan, K. L., Gelijns, A. C., Fumakia, N., Ghanta, R. K., et al. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.09.089 · Cited by 24
Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong
Chow, V. C. Y., Kwong, T. N. Y., So, E. W. M., Ho, Y. I. I., Wong, S. H., Lai, R. W. M., & Chan, R. C. Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-17523-7 · Cited by 24
Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital
Aldrich, A. M., Argo, T. A., Koehler, T. J., & Olivero, R. M. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002053 · Cited by 24
Outcomes of Community and Healthcare-onsetClostridium difficileInfections
Mora-Pinzon, M. C., Buie, R. W., Liou, J., Shirley, D. K., Evans, C. T., Ramanathan, S., Poggensee, L., & Safdar, N. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy715 · Cited by 24
Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers
McLure, A., Clements, A., Kirk, M., & Glass, K. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819000384 · Cited by 24
Clinical review of Clostridium difficile infection: an update on treatment and prevention
Daniels, L. M., & Kufel, W. D. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1524872 · Cited by 24
Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
Saleh, M. M., & Petri, W. A. (2019) · Infection and Immunity · doi:10.1128/iai.00306-19 · Cited by 23
Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027
Peng, Z., Simeon, R. L., Mitchell, S. B., Zhang, J., Feng, H., & Chen, Z. (2019) · mSphere · doi:10.1128/msphere.00596-19 · Cited by 24
The impact of an electronic medical record nudge on reducing testing for hospital-onset Clostridioides difficile infection
Howard-Anderson, J. R., Sexton, M. E., Robichaux, C. J., Wiley, Z., Varkey, J. B., Suchindran, S., Albrecht, B., Jones, K. A., Fridkin, S. K., & Jacob, J. T. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.12 · Cited by 25
Self-citation
Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection
Ray, M. J., Strnad, L. C., Tucker, K. J., Furuno, J. P., Lofgren, E., McCracken, C. M., Park, H., Gerber, J. S., & McGregor, J. C. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae259 · Cited by 23
Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection
Gilboa, M., Regev‐Yochay, G., Meltzer, E., Cohen, I., Peretz, Y., Zilberman‐Daniels, T., Segev, A., Amit, S., Yahav, D., & Barda, N. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.25252 · Cited by 23
Clostridioides difficile pathogenesis and control
Chilton, C. H., Viprey, V. F., Normington, C., Moura, I. B., Buckley, A. M., Freeman, J., Davies, K., & Wilcox, M. H. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01242-2 · Cited by 26
The growing problem of antimicrobial resistance
Holmstrup, P., & Klausen, B. (2016) · Oral Diseases · doi:10.1111/odi.12610 · Cited by 23
Shift to community-onset Clostridium difficile infection in the national Veterans Health Administration, 2003-2014
Reveles, K. R., Pugh, M. J., Lawson, K. A., Mortensen, E. M., Koeller, J. M., Argamany, J. R., & Frei, C. R. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.09.020 · Cited by 23
Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing
Kamboj, M., Brite, J., Aslam, A., Kennington, J., Babady, N. E., Calfee, D. P., Furuya, Y. E., Chen, D. S., Augenbraun, M. H., Ostrowsky, B. E., et al. (2018) · Emerging infectious diseases · doi:10.3201/eid2403.170961 · Cited by 23
Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin
Snydman, D. R., McDermott, L. A., Thorpe, C. M., Chang, J. H., Wick, J., Walk, S. T., & Vickers, R. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky135 · Cited by 23
Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study
Poirier, D., Gervais, P., Fuchs, M., Roussy, J.-F., Paquet-Bolduc, B., Trottier, S., Longtin, J., Loo, V. G., & Longtin, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz626 · Cited by 23
The prognostic value of toxin B and binary toxin in Clostridioides difficile infection
López-Cárdenas, S., Torres, E., Mora-Delgado, J., Sánchez-Calvo, J. M., Santos, M. L., López, Á. Z., López-Prieto, M. D., Pérez-Cortés, S., & Alados, J. C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1884516 · Cited by 23
Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis
Nelson, W. W., Scott, T. A., Boules, M., Teigland, C. L., Parente, A., Unni, S. K., & Feuerstadt, P. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.20395 · Cited by 26
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection
Carlson, T. J., Gonzales-Luna, A. J., & Garey, K. W. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1740973 · Cited by 23
Infection and inflammation stimulate expansion of a CD74+ Paneth cell subset to regulate disease progression
Balasubramanian, I., Bandyopadhyay, S., Flores, J., Bianchi‐Smak, J., Lin, X., Liu, H., Sun, S., Golovchenko, N. B., Liu, Y., Wang, D., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2023113975 · Cited by 24
Interaction of Clostridioides difficile infection with frailty and cognition in the elderly: a narrative review
Cotarelo, M., Jackson-Akers, J. Y., Nagy-Agren, S. E., & Warren, C. A. (2023) · European journal of medical research · doi:10.1186/s40001-023-01432-9 · Cited by 24
Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID)
Davies, K., Davis, G. L., Barbut, F., Eckert, C., Petrosillo, N., & Wilcox, M. H. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2746-1 · Cited by 23
Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice from Clostridium difficile infection
Yang, Z., Shi, L., Yu, H., Zhang, Y., Chen, K. Y., Fleur, A. S., Bai, G., & Feng, H. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw078 · Cited by 23
Proton pump inhibitors and risk of Clostridium difficile infection
Villafuerte-Gálvez, J., & Kelly, C. P. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000414 · Cited by 23
Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff, M. R. (2018) · Toxicon · doi:10.1016/j.toxicon.2017.11.003 · Cited by 23
Peptidoglycan degradation machinery in Clostridium difficile forespore engulfment
Dembek, M., Kelly, A., Barwinska‐Sendra, A., Tarrant, E., Stanley, W. A., Vollmer, D., Biboy, J., Gray, J., Vollmer, W., & Salgado, P. S. (2018) · Molecular Microbiology · doi:10.1111/mmi.14091 · Cited by 23
Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
Ilett, E. E., Helleberg, M., Reekie, J., Murray, D. D., Wulff, S. M., Khurana, M. P., Mocroft, A., Daugaard, G., Perch, M., Rasmussen, A., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz086 · Cited by 23
Risk factors for community-associated Clostridioides difficile infection in young children
Weng, M. K., Adkins, S. H., Bamberg, W., Farley, M. M., Espinosa, C. C., Wilson, L. E., Perlmutter, R., Holzbauer, S., Whitten, T., Phipps, E. C., et al. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819000372 · Cited by 23
Self-citation
Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen Clostridioides difficile
Bradshaw, W. J., Bruxelle, J.-F., Kovacs-Simon, A., Harmer, N. J., Janoir, C., Péchiné, S., Acharya, K. R., & Michell, S. L. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010120 · Cited by 23
Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection
White, N. C., Mendo-López, R., Papamichael, K., Cuddemi, C., Barrett, C. G., Daugherty, K., Pollock, N. R., Kelly, C. P., & Alonso, C. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz978 · Cited by 23
Regulation and Anaerobic Function of the Clostridioides difficile β-Lactamase
Sandhu, B. K., Edwards, A. N., Anderson, S. E., Woods, E. C., & McBride, S. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01496-19 · Cited by 25
The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China
Zhang, W., Li, W. G., Liu, Y., Gu, W., Zhang, Q. H., Li, H., Liu, Z., Zhang, X., Wu, Y., & Lu, J. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01757-z · Cited by 23
Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
Magill, S. S., Dumyati, G. K., Ray, S. M., & Fridkin, S. K. (2015) · Emerging infectious diseases · doi:10.3201/eid2109.150508 · Cited by 23
Self-citation
Laboratory-based surveillance of Clostridium difficile circulating in Australia, September – November 2010
Cheng, A. C., Collins, D. A., Elliott, B., Ferguson, J., Paterson, D. L., Thean, S. K., & Riley, T. V. (2016) · Pathology · doi:10.1016/j.pathol.2016.02.005 · Cited by 22
Comparative effectiveness of faecal microbiota transplant by route of administration
Gundacker, N. D., Tamhane, A. R., Walker, J. B., Morrow, C. D., & Rodriguez, J. M. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.05.004 · Cited by 22
Acquisition of Clostridium difficile Colonization and Infection After Transfer From a Veterans Affairs Hospital to an Affiliated Long-Term Care Facility
Ponnada, S., Guerrero, D. M., Jury, L. A., Nerandzic, M. M., Cadnum, J. L., Alam, M. J., & Donskey, C. J. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.140 · Cited by 22
SpoIVA-SipL Complex Formation Is Essential for Clostridioides difficile Spore Assembly
Touchette, M. H., de la Puebla, H. B., Ravichandran, P., & Shen, A. (2019) · Journal of Bacteriology · doi:10.1128/jb.00042-19 · Cited by 22
Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile
Carlucci, C., Jones, C. S., Oliphant, K., Yen, S., Daigneault, M. C., Carriero, C., Robinson, A. V., Petrof, E. O., Weese, J. S., & Allen‐Vercoe, E. (2019) · Scientific Reports · doi:10.1038/s41598-018-37547-x · Cited by 23
Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine‐2 receptor antagonists: A 15‐year hospital cohort study using a common data model
Seo, S. I., You, S. C., Park, C. H., Kim, T., Ko, Y. S., Kim, Y., Yoo, J. J., Kim, J., & Shin, W. G. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14983 · Cited by 22
Novel Bioactive Polyketides Isolated from Marine Actinomycetes: An Update Review from 2013 to 2019
Lu, S., Wang, J., Sheng, R., Fang, Y., & Guo, R. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000562 · Cited by 22
Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
Jiang, Y., Sarpong, E., Sears, P. S., & Obi, E. N. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00480-0 · Cited by 22
Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
Vecchio, L. E. D., Fiorani, M., Tohumcu, E., Bibbò, S., Porcari, S., Mele, M. C., Pizzoferrato, M., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2022) · Microorganisms · doi:10.3390/microorganisms10071315 · Cited by 22
Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases
Kayama, H., & Takeda, K. (2023) · European Journal of Immunology · doi:10.1002/eji.202249866 · Cited by 21
Increased Intestinal Permeability: An Avenue for the Development of Autoimmune Disease?
English, J., Connolly, L., & Stewart, L. D. (2023) · Exposure and Health · doi:10.1007/s12403-023-00578-5 · Cited by 27
De novo design of mini-protein binders broadly neutralizing Clostridioides difficile toxin B variants
Lv, X., Zhang, Y., Sun, K., Yang, Q., Luo, J., Tao, L., & Lu, P. (2024) · Nature Communications · doi:10.1038/s41467-024-52582-1 · Cited by 22
Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease
Spinler, J. K., Brown, A., Ross, C. L., Boonma, P., Conner, M. E., & Savidge, T. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.008 · Cited by 22
Development and Validation of a Risk Score for Clostridium difficile Infection in Medicare Beneficiaries: A Population‐Based Cohort Study
Zilberberg, M. D., Shorr, A. F., Wang, L., Başer, O., & Yu, H. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14236 · Cited by 22
Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile
Mehta, K. K., Paskaleva, E. E., Wu, X., Grover, N., Mundra, R. V., Chen, K., Zhang, Y., Yang, Z., Feng, H., Dordick, J. S., et al. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26029 · Cited by 22
Clostridium difficile Infection
Shin, J. H., Chaves‐Olarte, E., & Warren, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.ei10-0007-2015 · Cited by 22
Host response to Clostridium difficile infection: Diagnostics and detection
Usacheva, E. A., Jin, J., & Peterson, L. R. (2016) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.08.002 · Cited by 22
Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission
Stephenson, B., Lanzas, C., Lenhart, S., & Day, J. (2017) · Journal of Mathematical Biology · doi:10.1007/s00285-017-1133-6 · Cited by 22

Authors: Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., Wilson, L. E., Winston, L. G., Cohen, J. A., Limbago, B. M., Fridkin, S. K., Gerding, D. N., & McDonald, L. C.
Affiliations: National Center for Emerging and Zoonotic Infectious Diseases (US)
Colorado Department of Public Health and Environment (US)
Oregon Health Authority (US)
University of Rochester Medicine (US)
Tennessee Department of Health (US)
Emory University (US)
Office of Readiness and Response (US)
Yale University (US)
University of New Mexico (US)
Maryland Department of Health (US)
University of California, San Francisco (US)
Loyola University Chicago (US)
ORCID: Lessa, Fernanda C.
Mu, Yi
Bamberg, Wendy M.
Dumyati, Ghinwa K.
Dunn, John R.
Farley, Monica M.
Holzbauer, Stacy M.
Meek, James I.
Phipps, Erin C.
Wilson, Lucy E.
Fridkin, Scott K.
Gerding, Dale N.
McDonald, L. Clifford
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-02-26
Volume: 372
Issue: 9
Pages: 825-834
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1408913
PMC: PMC10966662
OpenAlex: W2071054182
Cited by: 2,641
References: 44
Citations by year: 2026: 94 · 2025: 111 · 2024: 120 · 2023: 150 · 2022: 176 · 2021: 225 · 2020: 328 · 2019: 382 · 2018: 356 · 2017: 323 · 2016: 262 · 2015: 108
FWCI: 270.42
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: other-oa
Locations: New England Journal of Medicine (publishedVersion, other-oa)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Maryland Shared Open Access Repository (USMAI Consortium) (submittedVersion, public-domain)
eScholarship (California Digital Library) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park) (public-domain)
Funders: National Institutes of Health (CC999999)
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords: Clostridium difficile infection, incidence, nosocomial infections, community-associated infections, recurrence, mortality, NAP1 strain, molecular typing, pulsed-field gel electrophoresis
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Clostridium Infections, Cross Infection, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Recurrence, United States, Bacterial Typing Techniques, Incidence, Clostridioides difficile, Electrophoresis, Gel, Pulsed-Field, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Burden of Clostridium difficile Infection in the United States

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks